Press Releases | Health Daily Finland

Explore more publications!

Press Releases

Global Health Leaders to Convene in London for Inaugural International Case Management Conference

Mar. 18, 2026

Global Health Leaders to Convene in London for Inaugural International Case Management Conference

GlobeNewswire, Inc.

Herantis Pharma to present HER-096 Phase 1b data at International Conference on Alzheimer’s & Parkinson’s Diseases

Mar. 16, 2026

Herantis Pharma to present HER-096 Phase 1b data at International Conference on Alzheimer’s & Parkinson’s Diseases

GlobeNewswire, Inc.

PsyMetRiC – a new tool to predict physical health risks in young people with psychosis

Mar. 12, 2026

PsyMetRiC – a new tool to predict physical health risks in young people with psychosis

EIN Presswire

Mar. 12, 2026

Aplagon Announces First Patient Dosed in Phase 2a Clinical Trial of APAC in Patients with Peripheral Arterial Occlusive Disease / Chronic Limb Threatening Ischemia

GlobeNewswire, Inc.

Albanian-Finnish Startup Bliss Raises $270K to Build Culturally Intelligent AI for Therapy

Mar. 11, 2026

Albanian-Finnish Startup Bliss Raises $270K to Build Culturally Intelligent AI for Therapy

GlobeNewswire, Inc.

Herantis Pharma releases 2H and FY 2025 report today

Mar. 5, 2026

Herantis Pharma releases 2H and FY 2025 report today

GlobeNewswire, Inc.

Mar. 2, 2026

Living with a Rare Disease: A Pastor’s Journey Finding the Right Care and Treatment for NF1-PN

GlobeNewswire, Inc.

A Guide to Philadelphia’s Top Luxury Wellness & Recovery Spots

Feb. 27, 2026

A Guide to Philadelphia’s Top Luxury Wellness & Recovery Spots

Visit Philly - Pennsylvania

Owner: Greater Philadelphia Tourism Marketing Corporation

Visit Philly

Owned By	Greater Philadelphia Tourism Marketing Corporation (Non-profit, Angela Val CEO)
Year Founded	1996
Website	https://www.visitphilly.com/
Domain Registration Year	1999
Access Type	open
Publication Location	United States, Pennsylvania, Philadelphia
Owner Country	United States

We welcome your feedback!
If you have comments or corrections, let us know.

Feb. 23, 2026

Alps Group Inc Publishes Clinical Safety, Tolerability and Effectiveness Data Supporting Advancement of Its Autologous NK Cell Pipeline Using an In-House Developed Culture Protocol

GlobeNewswire, Inc.

Feb. 23, 2026

This American Heart Month Amarin Spotlights the Need to Prioritize Proven Widely Available Yet Underutilized Therapies in the Battle Against Cardiovascular Disease

GlobeNewswire, Inc.

Mar. 18, 2026

Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline

GlobeNewswire, Inc.

Mar. 18, 2026

VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland

GlobeNewswire, Inc.

Mar. 18, 2026

VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland

GlobeNewswire, Inc.

GLP-1 medications used to treat diabetes and obesity may also help alleviate symptoms of anxiety and depression

Mar. 19, 2026

GLP-1 medications used to treat diabetes and obesity may also help alleviate symptoms of anxiety and depression

GlobeNewswire, Inc.

Mar. 18, 2026

VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland

GlobeNewswire, Inc.

Mar. 18, 2026

VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland

GlobeNewswire, Inc.

Mar. 16, 2026

New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual…

GlobeNewswire, Inc.

Researchers Break Decades-old Bottleneck in Chemotherapy Drug Manufacturing

Mar. 13, 2026

Researchers Break Decades-old Bottleneck in Chemotherapy Drug Manufacturing

EIN Presswire

Mar. 10, 2026

VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland

GlobeNewswire, Inc.

Mar. 10, 2026

VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland

GlobeNewswire, Inc.